Literature DB >> 2992157

Molecular cloning of integrated caprine arthritis-encephalitis virus.

A Yaniv, J E Dahlberg, S R Tronick, I M Chiu, S A Aaronson.   

Abstract

A full-length DNA clone of the exogenous retrovirus, caprine arthritis-encephalitis virus (CAEV), was isolated from high molecular weight DNA of CAEV-infected Himalayan tahr ovary cells. Although other restriction maps of CAEV have been published, this is the first time that the proviral DNA has been cloned. The restriction enzyme map of the clone was determined and found to be identical to that of unintegrated linear CAEV DNA except for the presence of cellular flanking sequences. These findings establish that lentiviruses are able to integrate within the infected host cellular genome. The cloned CAEV genome was shown to contain terminal repeats of approximately 450 base pairs in length, and its restriction enzyme map was oriented with respect to the direction of viral RNA transcription. When the cloned CAEV DNA was used as a molecular probe, it failed to detect related proviral sequences in the genomes of a variety of vertebrate species, including the goat, sheep, horse, mouse, and man. When CAEV DNA was hybridized under relaxed conditions to a variety of cloned DNAs, representing different oncoviral genera, homology to mouse mammary tumor virus (MMTV) was observed, while no homology to avian type C or mammalian type A, C, and D retroviruses was detected. This homology was localized to a region in MMTV corresponding to the 3' end of the gag gene and the 5' end of the pol gene.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992157     DOI: 10.1016/0042-6822(85)90169-2

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Localization of sequences responsible for trans-activation of the equine infectious anemia virus long terminal repeat.

Authors:  L Sherman; A Gazit; A Yaniv; T Kawakami; J E Dahlberg; S R Tronick
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

2.  A long term study of goats naturally infected with caprine arthritis-encephalitis virus.

Authors:  J Hanson; E Hydbring; K Olsson
Journal:  Acta Vet Scand       Date:  1996       Impact factor: 1.695

3.  Detection of caprine arthritis-encephalitis- and maedi-visna viruses using the polymerase chain reaction.

Authors:  R Zanoni; U Pauli; E Peterhans
Journal:  Experientia       Date:  1990-03-15

4.  Sequence homology between cloned caprine arthritis encephalitis virus and visna virus, two neurotropic lentiviruses.

Authors:  J M Pyper; J E Clements; M A Gonda; O Narayan
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

5.  Analysis of regulatory elements of the equine infectious anemia virus and caprine arthritis-encephalitis virus long terminal repeats.

Authors:  L Sherman; A Yaniv; H Lichtman-Pleban; S R Tronick; A Gazit
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

6.  Two species of Rev proteins, with distinct N termini, are expressed by caprine arthritis encephalitis virus.

Authors:  A Gazit; P Mashiah; H Kalinski; A Gast; R Rosin-Abersfeld; S R Tronick; A Yaniv
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

7.  Maedi-visna virus and caprine arthritis-encephalitis virus: distinct species or quasispecies and its implications for laboratory diagnosis.

Authors:  J Pasick
Journal:  Can J Vet Res       Date:  1998-10       Impact factor: 1.310

8.  Phosphorothioate oligonucleotides inhibit the replication of lentiviruses and type D retroviruses, but not that of type C retroviruses.

Authors:  D Archambault; C A Stein; J S Cohen
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

Review 9.  Human immunodeficiency virus type 1 infection of the brain.

Authors:  W J Atwood; J R Berger; R Kaderman; C S Tornatore; E O Major
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

10.  Separate epitopes in the envelope of visna virus are responsible for fusion and neutralization: biological implications for anti-fusion antibodies in limiting virus replication.

Authors:  S E Crane; J E Clements; O Narayan
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.